SERPINF1 and prostate adenocarcinoma: Previous studies have demonstrated that 34-mer domain exerts the antiangiogenic activity of PEDF [10], [27] and suppresses angiogenesis in animals with choroidal neovascularization [27] or PC-3 prostate adenocarcinomas [10].